These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37462593)

  • 1. Impact of Complete Revascularization in the ISCHEMIA Trial.
    Stone GW; Ali ZA; O'Brien SM; Rhodes G; Genereux P; Bangalore S; Mavromatis K; Horst J; Dressler O; Poh KK; Nath RK; Moorthy N; Witkowski A; Dwivedi SK; Bockeria O; Chen J; Smanio PEP; Picard MH; Chaitman BR; Berman DS; Shaw LJ; Boden WE; White HD; Fremes SE; Rosenberg Y; Reynolds HR; Spertus JA; Hochman JS; Maron DJ;
    J Am Coll Cardiol; 2023 Sep; 82(12):1175-1188. PubMed ID: 37462593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.
    Mavromatis K; Jones PG; Ali ZA; Stone GW; Rhodes GM; Bangalore S; O'Brien S; Genereux P; Horst J; Dressler O; Goodman S; Alexander K; Mathew A; Chen J; Bhargava B; Uxa A; Boden WE; Mark DB; Reynolds HR; Maron DJ; Hochman JS; Spertus JA;
    J Am Coll Cardiol; 2023 Jul; 82(4):295-313. PubMed ID: 37468185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
    Redfors B; Stone GW; Alexander JH; Bates ER; Bhatt DL; Biondi-Zoccai G; Caldonazo T; Farkouh M; Rahouma M; Puskas J; Sandner S; Gaudino MFL
    J Am Coll Cardiol; 2024 Feb; 83(5):549-558. PubMed ID: 37956961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial.
    Gaudino M; Alexander JH; Sandner S; Harik L; Kim J; Stone GW; Rahouma M; O'Gara P; Bhatt DL; Redfors B
    EuroIntervention; 2024 May; 20(9):551-560. PubMed ID: 38444364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Lopez-Sendon JL; Cyr DD; Mark DB; Bangalore S; Huang Z; White HD; Alexander KP; Li J; Nair RG; Demkow M; Peteiro J; Wander GS; Demchenko EA; Gamma R; Gadkari M; Poh KK; Nageh T; Stone PH; Keltai M; Sidhu M; Newman JD; Boden WE; Reynolds HR; Chaitman BR; Hochman JS; Maron DJ; O'Brien SM
    Eur Heart J; 2022 Jan; 43(2):148-149. PubMed ID: 34514494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Reynolds HR; Shaw LJ; Min JK; Page CB; Berman DS; Chaitman BR; Picard MH; Kwong RY; O'Brien SM; Huang Z; Mark DB; Nath RK; Dwivedi SK; Smanio PEP; Stone PH; Held C; Keltai M; Bangalore S; Newman JD; Spertus JA; Stone GW; Maron DJ; Hochman JS
    Circulation; 2021 Sep; 144(13):1024-1038. PubMed ID: 34496632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial.
    Ali ZA; Garcia JJ; Karimi Galougahi K; Horst J; Gallo A; Shin D; Ben-Yehuda O; Chen S; Redfors B; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2024 Mar; 17(3):e013192. PubMed ID: 38502720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.
    Williams DO; Braunwald E; Knatterud G; Babb J; Bresnahan J; Greenberg MA; Raizner A; Wasserman A; Robertson T; Ross R
    Circulation; 1992 Feb; 85(2):533-42. PubMed ID: 1735149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Nagaraja V; Ooi SY; Nolan J; Large A; De Belder M; Ludman P; Bagur R; Curzen N; Matsukage T; Yoshimachi F; Kwok CS; Berry C; Mamas MA
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27986755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
    Sheth T; Pinilla-Echeverri N; Moreno R; Wang J; Wood DA; Storey RF; Mehran R; Bainey KR; Bossard M; Bangalore S; Schwalm JD; Velianou JL; Valettas N; Sibbald M; Rodés-Cabau J; Ducas J; Cohen EA; Bagai A; Rinfret S; Newby DE; Feldman L; Laster SB; Lang IM; Mills JD; Cairns JA; Mehta SR
    J Am Coll Cardiol; 2020 Sep; 76(11):1277-1286. PubMed ID: 32912441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Complete or Incomplete Revascularization for Left Main Coronary Disease: The Extended PRECOMBAT Study.
    Kim T; Kang DY; Kim S; Lee JH; Kim AR; Lee Y; Oh HJ; Jang M; Lee J; Kim JH; Lee PH; Ahn JM; Park SJ; Park DW;
    JACC Asia; 2023 Feb; 3(1):65-74. PubMed ID: 36873760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.